Several short peptides appear repeatedly in published tissue-repair and inflammation research. Below is a brief overview of four of them, what they are, and the kinds of research models they
BPC-157 and TB-500 are often mentioned together, but they are distinct molecules with different origins and research histories. BPC-157 Synthetic pentadecapeptide (15 amino acids) derived from a gastric protein sequence
Retatrutide (LY3437943) is an investigational peptide developed by Eli Lilly. It is a single molecule designed to act on three receptors: GLP-1, GIP and glucagon, which is why it is